Skip to main content
. 2018 Jun 1;8(6):1074–1082.

Table 2.

Adverse events according to regimen

Adverse Events CP (n=241) NP (n=195) P (Grade 3-4)


Grade ≥1 Grade ≥2 Grade 3-4 Grade ≥1 Grade ≥2 Grade 3-4






N % N % N % N % N % N %
Neutropenia 195 80.99 81 33.6 109 55.9 26 13.3 <0.001
Febrile neutropenia 9 3.73 3 1.5 0.24
Thrombocytopenia 42 17.4 35 14.5 31 15.9 11 5.6 0.003
Anemia 139 57.7 16 6.6 92 47.2 8 4.1 0.261
P (Grade ≥2)
Alopecia 193 80.1 165 68.55 152 77.9 133 68.2 0.954
Nausea 156 64.7 75 31.1 107 54.9 47 24.1 0.105
Vomiting 79 32.8 34 14.1 68 34.9 33 16.9 0.418
Constipation 118 48.9 32 13.3 103 52.8 27 13.8 0.863
Diarrhea 72 29.9 27 11.2 63 32.3 19 9.7 0.662
Fatigue 187 77.6 90 37.3 136 69.7 72 36.9 0.928
Neuropathy 103 42.7 43 17.8 95 48.7 36 18.5 0.867
Allergy 53 21.9 38 15.8 11 5.8 7 3.7 <0.001

Abbreviations: CP, carboplatin and paclitaxel; NP, nedaplatin and paclitaxel.